abstract |
The present invention relates to the use of a rosemary extract in the preparation of a composition for treating a cancer, in which there is a change in oestrogen signalling or lipid metabolism, to a composition comprising rosemary extract and a chemotherapeutic agent, and also to an in‑vitro method for predicting the clinical response to an anti‑tumour therapy using said composition. |